Metformin for the management of insulin resistance in overweight women at midlife
Description of the study:
The purpose of this project is to assess the effects of Metformin on insulin sensitivity (which helps prevent progression to type 2 diabetes), weight loss and lipids such as cholesterol. This study runs for 6 months and involves taking an oral study medication or placebo for this period. The participant is required to visit the study centre 4 times for medical assessments and observations.
Inclusion criteria:
- Aged between 45 and 65 years
- No use of systemic hormones in the past 3 months
- A BMI >30kg/m2 and <40kg/m2 and a waist circumference >88cm
- Post menopausal
- In good health
Ethics Approval:
Monash University Human Research Ethics Committee-MUHREC Project Number: CF10/1417 – 2010000757 (WHP 2010/9)
Geographical location of study:
Prahran
Principal Investigator:
Professor Susan Davis
Contact details:
For more information please contact us on: Phone: (03) 9903 0820 Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Website:http://womenshealth.med.monash.edu.au
Content updated 6 October 2010
Last Updated (Monday, 30 April 2012 09:30)

